The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 79, Issue 2, 2000, Pages 140-144

  Lin, Hao ^a   ChangChien, Chan Chao ^a   Huang, Eng Yen ^a   Tseng, Chih Wen ^a   Eng, Hock Liew ^a   Huang, Chao Cheng ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cervical cancer; Lymph node metastasis; Squamous cell carcinoma antigen

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PATHOLOGY; PELVIS LYMPH NODE; PREDICTION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; TUMOR VOLUME; UTERINE CERVIX CANCER;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYSTERECTOMY; LOGISTIC MODELS; LYMPHATIC METASTASIS; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PATIENT SELECTION; PREOPERATIVE CARE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SERPINS; STATISTICS, NONPARAMETRIC; UTERINE CERVICAL NEOPLASMS;

EID: 0033976160     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2000.079002140.x     Document Type: Article

References (28)

1. 1. Shingleton HM, Gore H, Soong SJ, Orr JW Jr, Hatch KD, Austin JM et al. Tumor recurrence and survival in stage Ib cancer of the cervix. Am J Clin Oncol 1983; 6(3): 265.
2. 2. Noguchi H, Shiozawa I, Sakai Y, Yamazsaki T, Fukuta T. Pelvic lymph node metastasis of uterine cervical cancer. Gynecol Oncol 1987; 27: 150-8.
3. 3. Jobson VW, Girtanner RE, Averette HE. Therapy and survival of early invasive carcinoma of the cervix uteri with metastases to the pelvic nodes. Obstet Gynecol 1980; 151: 27-9.
4. 4. Kinney WK, Alvarez RD, Reid GC, Schray MF, Soong SJ, Morley GW et al. Value of adjuvant whole-pelvic irradiation after Wertheim hysterectomy for early-stage squamous cell carcinoma of the cervix with pelvic nodal metastasis: a matched control study. Gynecol Oncol 1989; 34: 258-62.
5. 5. Russell AH, Tong DY, Figge DC, Tamimi HK, Greer BE, Elder SJ. Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix: pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadenectomy. Int J Radiat Oncol Biol Phys 1984; 10: 211-14.
6. 6. Hogan WM, Littman P, Griner L, Miller CL, Mikuta JJ. Results of radiation therapy given after radical hysterectomy. Cancer 1982; 49: 1278-85.
7. 7. Potter ME, Alvarez RD, Shingleton HM, Soong SJ, Hatch KD. Early invasive cervical cancer with lymph node involvement: to complete or not to complete radical hysterectomy? Gynecol Oncol 1990; 37: 78-81.
8. 8. Bremer GL, van der Putten HW, Dunselman GA, de Haan J. Early stage cervical cancer: aborted versus completed radical hysterectomy. Eur J Obstet Gynecol Reprod Biol 1992; 47: 147-51.
9. 9. Weiser EB, Bundy BN, Hoskins WJ, Heller PB, Whittington RR, DiSaia PJ et al. Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 1989; 33: 283-9.
10. 10. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy: A multivariate analysis of prognostic variables in the Gynecology Oncology Group. Cancer 1991; 67: 2776-85.
11. 11. Grumbine FC, Rosenshein NB, Zerhouni EA, Siegelman SS. Abdominopelvic computed tomography in the preoperative evaluation of early cervical cancer. Gynecol Oncol 1981; 12: 286-90.
12. 12. Chen SS, Kumari S, Lee L. Contribution of abdominal computed tomography (CT) in the management of gynecologic cancer: Correlated study of CT image and gross surgical pathology. Gynecol Oncol 1980; 10: 162-72.
13. 13. Matsukuma K, Tsukamoto N, Matsuyama T, Ono M, Nakano H. Preoperative CT study of lymph nodes in cervical cancer - Its correlation with histological findings. Gynecol Oncol 1989; 33: 168-71.
14. 14. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 1997; 278(13): 1096-101.
15. 15. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977; 40: 162-8.
16. 16. Kato H, Morioka H, Tsutsui H, Aramaki S, Torigoe T. Value of tumor antigen (TA-4) of squamous cell carcinoma antigen in predicting the extent of cervical cancer. Cancer 1982; 50: 1294-6.
17. 17. Duk JM, de Bruun HWA, Groenier KH, Hollema H, Hoor HAT, Krans M et al. Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecol Oncol 1990; 39: 186-94.
18. 18. Patsner B, Orr Jr JW, Allmen T. Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix? Obstet Gynecol 1989; 75: 786-8.
19. 19. Bolger BS, Dabbas M, Lopes A, Monaghan JM. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma. Gynecol Oncol 1997; 65: 309-13.
20. 20. Takeshima N, Hirai Y, Katase K, Yano K, Yamauchi K, Hasumi K. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer. Gynecol Oncol 1998; 68: 263-6.
21. 21. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995; 86: 43-50.
22. 22. Kim SH, Choi BI, Lee HP, Kang SB, Choi YM, Han MC et al. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology 1990; 175: 45-51.
23. 23. Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 1994; 190: 807-11.
24. 24. Hawnaur JM, Johnson RJ, Buckley CH, Tindall V, Isherwood I. Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin Radiol 1994; 49: 443-52.
25. 25. Heller PB, Maletano JH, Bundy BN, Barnhill DR, Okagaki T. Clinical-pathologic study of stage IIB, III and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study. Gynecol Oncol 1990; 38: 425-30.
26. 26. Swart E, Bouma J, Schuur K. The clinical value of lymphography in cervical cancer, FIGO-stage Ib-IIa. Eur J Gynaecol Oncol 1989; 10: 85-90.
27. 27. Stenman J, Lintula S, Hotakainen K, Vartiainen J, Lehvaslaiho H, Stenman UH. Detection of squamous-cell carcinoma antigen-expressing tumor cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix. Int J Cancer 1997; 74: 75-80.
28. 28. Tseng CJ, Pao CC, Lin JD, Soong YK, Hong JH, Hsueh S. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol 1999; 17: 1391-6.